Cellulose nanocrystals (CNCs) have remarkable potential to improve the delivery of diagnostic and therapeutic agents to tumors, however, the in vivo studies on CNC biodistribution are still limited. We developed CNC-based imaging probes for the in vitro and in vivo evaluation using two labeling strategies: site-specific hydrazone linkage to the terminal aldehyde of the CNC and non-site-specific activation using 1,1'-carbonyldiimidazole (CDI). The in vivo behavior of unmodified CNC, DOTA-CNC (ald.), and DOTA-CNC (OH) was investigated in healthy and 4T1 breast cancer mouse models. They displayed good biocompatibility in cell models. Moreover, the biodistribution profile and SPECT/CT imaging confirmed that the accumulation of 111 In-labeled DOTA-CNC (ald.) and 111 In-DOTA-CNC (OH) was primarily in hepatic, splenic, and pulmonary ducts in accordance with the clearance of nontargeted nanoparticles. The developed CNC imaging probes can be used to obtain information with non-invasive imaging on the behavior in vivo to guide structural optimization for targeted delivery.
INTRODUCTION 3
The development of biocompatible nanomaterials has had a tremendous impact on the targeted delivery of therapeutic and diagnostic agents in cancer. [1] [2] [3] [4] [5] Nanomaterials have been extensively used as nanocarriers in order to achieve successful delivery of therapeutic payloads, contrast agents and diagnostic/therapeutic radionuclides to the tumor while reducing systemic side effects after administration in vivo. [6] [7] [8] Molecular imaging techniques are already widely employed in the early detection of malignant lesions, tumor biochemical characterization, disease staging and monitoring of treatment response. [9] [10] Single-photon emission computed tomography (SPECT), based on the detection of gamma (γ) radiation emitted by radioactive isotopes, such as Tc-99m, In-111, I-123, and Lu-177, is an important non-invasive imaging method in oncology clinical practice. SPECT imaging is a widely used modality in the clinic due to its relatively low cost compared to positron emission tomography (PET), often facile radiopharmaceutical synthesis, and the availability of a number of isotopes with relatively long (>10 hours) and multi-day half-lives allowing for transport of the prepared radiotracers. [11] [12] Additionally, the energy resolution in SPECT instrumentation allows for the simultaneous imaging with multiple isotopes. 13 With the appropriate choice of radiotracer, SPECT imaging can render valuable information on tissue biochemistry, function, and metabolism. The development of nanoparticle-based imaging probes for nuclear imaging has created the capability to determine the disease location, monitor pathological and molecular changes related to payload delivery, as well as the comprehensive view of the material behavior in vivo in order to use as a guideline for therapeutic and diagnostic interventions with nanoscale drug delivery systems. [14] [15] [16] Cellulose is an inexhaustible, renewably-sourced biopolymer present in plants, select micro-organisms, and even in some marine invertebrates. [17] [18] [19] [20] The natural cellulose consists of amorphous (disordered) and crystalline regions. When mechanical (e.g. high-pressure homogenization, ultrasound) and chemical (e.g. strong acid hydrolysis) treatments are applied to bulk cellulose, the highly crystalline regions can be simply separated from the amorphous fractions to yield cellulose nanocrystals (CNCs). [21] [22] CNCs are needle-like nanoparticles comprising of glucose repeating units linked together by glycosidic oxygen bridges forming a linear homopolymer. The dimensions of CNCs vary depending on the source of the bulk cellulose and the treatment conditions. Acid hydrolysis of cotton (used in this study) typically yields CNCs of 5-10 nm in width and 100-300 nm in length, demonstrating a high aspect (L/D) ratio. [23] [24] The as-hydrolyzed CNC surface is covered with numerous hydroxyl groups from the glucose units and has an aldehyde group at the reducing end of the polymer chain that allow several types of chemical modifications, for example using: esterification, amination, oxidation, and polymer engraftment. [25] [26] [27] The abovementioned physicochemical properties of CNCs offer several advantages for biomedical and drug delivery applications, including the use as an excipient for the controlled release of hydrophobic drugs and enhancing drug bioavailability, loading capacity in aerogels, and in viral delivery applications. 26, [28] [29] [30] [31] The biosafety of novel nanomaterials has always been a critical issue because the changes in size, morphology, surface chemistry, charge and the degree of crystallinity can affect the behavior of the nanomaterials in vitro and in vivo. [32] [33] CNC-based biomaterials have demonstrated good biocompatibility, biodegradability, and low cytotoxicity in cell models. [34] [35] However, the reports on CNC-based drug delivery system behavior after systemic administration are still limited. 36 Here, we developed CNC-based nuclear imaging probes for evaluating their behavior in biological systems in vitro and in vivo. The macrocyclic radiometal chelator, DOTA (1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid), was covalently installed on the surface of CNCs by two different conjugation methods. Firstly, DOTA was conjugated to the aldehyde group (−CHO) at the reducing end of CNC as a hydrazide. Secondly, the hydroxyl groups (−OH) on the CNCs surface were activated with 1,1´-carbonyldiimidazole (CDI) and further conjugated with a DOTA-amine. The in vitro cytotoxicity of the two types of DOTA-installed CNCs was investigated in murine RAW 264.7 macrophages and murine 4T1 mammary adenocarcinoma cell line. Then, the DOTA-installed CNC were 5 radiolabeled with 111 In (t1/2 = 2.80 d, Eγ = 171.280 keV (Iγ 90%) and Eγ = 245.395 keV (Iγ 94%)), a diagnostic radionuclide for SPECT imaging (Figure 1a-1b) . The in vivo fate of DOTA-CNC prepared using the two synthetic strategies was determined in healthy and 4T1-tumor-bearing mice after intravenous administration by in vivo small-animal SPECT/CT imaging and ex vivo gamma counting of the excised tissues. 
EXPERIMENTAL SECTION

Materials and chemicals
CNCs were prepared from cotton fibers (Whatman ® filter paper) through acid hydrolysis as described in the literature. [37] [38] Prior to the synthetic modifications, CNCs were washed with 5× DMSO and 2× ultrapure water in order to remove the acid and sulfate residues, then collected back in powder form by lyophilizer. All chemicals and solvents were obtained from Sigma-Aldrich (St. Louis, MO, USA), VWR (Radnor, PA, USA), Macrocyclics (Plano, TX, USA), and Thermo Fisher Scientific (Waltham, MA, USA), and were used without further purification. The dialysis tubing was purchased from Spectrum Labs (Rancho Dominguez, CA, USA). Ultrapure water (18.2 MΩ) was prepared on a Milli-Q Integral 10 water purification system. The cell viability assay, culturing media, and other procedures for cell experiments are described in the Supporting Information (SI).
DOTA-CNCs preparation
In this study, there were two strategies of installing the DOTA chelator to the CNCs. First is the conjugation of DOTA hydrazide with aldehyde group at the reducing end of CNCs. The DOTA functionalized hydrazide (1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic acid)-10-acethydrazide or DOTA-NH-NH2) was synthesized in-house from 1,4,7,10-tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-acetic acid precursor (DOTA-tris (t-Bu ester), Macrocyclics, Plano, TX, USA) through amide coupling reaction and Boc-deprotection as described in the SI. The CNCs were dispersed in anhydrous DMSO at 5 mg/ml in a conical centrifuge tube and sonicated with tip sonicator (tip ϕ = 3 mm., SONIC Inc., CT, USA) at 20% amplitude for 5 min. Then, the CNCs solution was transferred to a round bottom flask and flushed with argon flow for 10 min with constant magnetic agitation. The DOTA-NH-NH2 (1 eq. w/w) was added to the CNCs dispersion under argon atmosphere. The reaction was left for 4 days in temperature-controlled oil bath at 50-60 °C. The reaction was terminated by centrifugation at 4000 rpm, 5 min to collect the pellet of DOTA-CNC (ald.). The DOTA-NH-NH2 residues in the product pellet were washed out with 4× fresh DMSO and dialysed against ultrapure water in a dialysis tube (MWCO 3.5-5.0 kDa) for at least 4 days while changing the medium at least twice a day. The purified DOTA-CNC (ald.) in aqueous solution was dried in a lyophilizer.
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The DOTA-amine (1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic acid)-10-(4-aminobutyl) acetamide or DOTA-NH2) was conjugated to the hydroxyl groups on the CNC surface through CDImediated amide coupling reaction. The CNCs were dissolved in anhydrous DMSO at a concentration of 5 mg/ml and subjected to sonication as described above. CDI (2 eq. w/w) in anhydrous DMSO was Moreover, the morphology and dimensions of unmodified and modified CNCs were characterized by 120 kV transmission electron microscopy (Tecnai 12 Bio-Twin FEI, Hillsboro, OR, USA). The unmodified and modified CNCs were dissolved in ultrapure water at 1 mg/ml and sonicated for 5 min.
Then, 5 µl of each CNC solution were applied on glow discharge treated carbon support film hexagonal 300 mesh copper grids (Electron Microscopy Sciences, PA, USA) and further negatively stained with 1% uranyl acetate for 2 min before leaving for 2 h of air-drying prior to the measurements.
In vitro cytotoxicity studies
The in vitro cytotoxicity was performed using a commercial CellTiter-Glo ® cell viability assay (Promega Corp., Madison, WI, USA). Murine RAW 264.7 macrophages and murine 4T1 mammary adenocarcinoma cell lines were selected as immune and tumor cell models. The cells were seeded overnight on a 96-well plate at density of 15,000 cells per well in 100 µl DMEM and RPMI-1640 media for RAW 264.7 and 4T1 cells, respectively. The medium was discarded and replaced with 100 µl of unmodified CNC, DOTA-CNC (ald.), and DOTA-CNC (OH) solutions at 5, 25, and 100 µg/ml, prepared in complete growth media for each cell line. Triton X-100 solution (1% v/v) and fresh medium were used as negative and positive controls of viability, respectively. Cells were incubated for 6, 24, 48, and 72 h at an incubator at 37 °C (5% CO2 concentration and 95% relative humidity). The assay was carried out according to the instructions from the manufacturer, reading the luminescence from the ATP activity produced in each well with Varioskan LUX multimode microplate reader (Thermo Fisher Scientific Inc., NY, USA). All measurements were done in triplicate.
In-radiolabeling of DOTA-modified CNCs
The DOTA-CNC (ald.) and DOTA-CNC (OH) were radiolabeled with 111 InCl3 (Mallinckrodt Medical B.V., Petten, the Netherlands). All radiolabeling solutions were prepared in ultrapure water rendered metal-free by treatment with Chelex 100 ion exchange resin (Bio-Rad, Hercules, CA, USA). Both DOTA-modified CNCs (1 mg) were dispersed in 0.2 M ammonium acetate buffer (pH 4.0) at a concentration of 1 mg/ml in a Protein LoBind microtube (Eppendorf, Hamburg, Germany). The solutions were sonicated with tip sonicator at 20% amplitude for 3 min before radiolabeling. The 111 InCl3 solution (30-150 MBq) was added to the DOTA-CNCs solution and the reaction mixtures were incubated at 100 °C for 60 min on a shaker. The radiolabeling reaction was quenched with 100 µl of 50 mM EDTA solution and allowed to equilibrate to room temperature before purification. The 111 In-DOTA-CNCs pellet was collected by centrifugation at 10 000g, 5 min. The supernatant was discarded and the product pellets were washed with 3× 50 mM of EDTA solution, 2 times with 1×PBS (pH 7.4), and 1× ultrapure water in order to release the non-specifically absorbed 111 In on the CNC surface. The radioactivity in the pellet and supernatant was measured by VDC-405 dose calibrator (Comecer Group, Joure, the Netherlands) after every step. The purified product pellets were resuspended in sterilized 1×PBS (pH 7.4) and sonicated for 2 min before supplementing the buffer with the Solutol HS 15 solubilizer (BASF ChemTrade GmbH, Burgbernheim, Germany) to a final concentration of 5% (v/v). The quality control of the products was checked by radio-TLC. The products were spotted on the glass microfiber chromatography sheet impregnated with a salicylic acid (iTLC-SA, Agilent Technologies, Folsom, CA, USA) and chromatogram was run in 0.2 M of sodium acetate buffer (pH 4.0) where the 111 In-DOTA-CNC products retains at the origin and the free 111 In 3+ moves along with the solvent (Rf = 0.74).
Radiolabel stability
The radiolabel stability of 111 In-DOTA-CNC (ald.) and 111 In-DOTA-CNC (OH) were conducted in simulated physiological conditions: 1× PBS (pH 7.4) and 50% human plasma. The 111 In-DOTA-CNCs were dissolved in those conditions at 100 µg/ml and incubated at 37 °C with constant shaking at 300 rpm (Eppendorf Thermomixer ® C, Eppendorf, Hamburg, Germany). Samples were drawn at specified time points (6, 24, 48 , and 72 h) for radio-TLC in order to determine the percent of intact 111 In on the CNC.
All assays were carried out in triplicate.
EDTA and Fe 3+ challenges
The 111 In-DOTA-CNC (ald.) and 111 In-DOTA-CNC (OH) were incubated in EDTA (2 mM) and FeCl3 (0.2 mM) at nanocrystal concentration of 100 µg/ml at 37 °C, 300 rpm. Samples were spotted on the radio-TLC at 3, 24, 48, 72, 96, and 120 h. The radio-TLC chromatogram was run in 0.2 M sodium acetate buffer (pH 4.0). The percent of 111 In intact in the CNC was quantified by autoradiography (Fujifilm Fluorescent Image Analyzer (FLA-5100), Fuji Film Photo, Tokyo, Japan). The experiments were run in triplicate.
Ex vivo biodistribution
The ex vivo biodistribution study was carried out in healthy female mice (CD-1, Charles River, 
RESULTS AND DISCUSSION
DOTA-modified CNCs characterization
The CNC nanoprobes, DOTA-CNC (ald.) and DOTA-CNC (OH), were successfully prepared through hydrazide-aldehyde and amide coupling reactions, respectively. The DOTA-CNC (ald.) was prepared by the conjugation of DOTA-hydrazide (1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic acid)-10-acethydrazide) to the aldehyde group at the reducing end of CNC. The DOTA-hydrazide chelator was successfully synthesized and characterized by 1 H and 13 (Figure S3) . Moreover, the elemental compositions (C, H, and N) of the unmodified and modified CNC were also quantified ( Table 1) . There was no significant difference in C and H compositions, because C and H are major constituents of the CNC homopolymer, however, there was an increase in N content from the nitrogen bonding after the conjugations. The N content of DOTA-CNC (ald.) was 0.10 % while in DOTA-CNC (OH) the value was 9-fold higher due to a higher number of CDI-activated hydroxyl conjugating sites for the DOTA-amine. Furthermore, the surface charge of unmodified and modified CNC is also an important parameter determining material dispersity, cell interactions and plasma protein adsorption in vivo. The DOTA-modified CNCs showed an increasing trend in surface charge in which the ζ-potential of DOTA-CNC (OH) was about 2-fold higher than unmodified CNC while DOTA-CNC (ald.) was slightly increased ( Table 1) . However, the DOTA-modified CNCs still maintained an optimal negative charge for stabilizing the CNC nanoparticles in suspension and reducing the nonspecific adsorption of plasma proteins in vivo. 39 TEM images were acquired to determine the morphology of the CNCs after the modifications. 
In vitro cytotoxicity studies
The in vitro cytotoxicity of unmodified and modified CNCs was investigated to evaluate the initial biosafety of the nanoparticles. The cytocompatibility assay with unmodified and DOTA-modified CNCs was carried out in a macrophage cell line (RAW 264.7), which is a good model of nanoparticle uptake and clearance in vivo. In addition, a tumor cell line (4T1 breast cancer) for the preliminary assessment of suitability for drug delivery applications was also studied. The unmodified and modified CNC were incubated with the cells at concentrations of 5, 25, and 100 µg/ml for 6, 24, 48, and 72 h. The cell viability was determined by the measurement of metabolic activity-generated luminescence from the ATP production in viable cells when reacting with CellTiter-Glo® cell viability assay reagent. The results demonstrated that the three types of CNCs displayed good biocompatibility at all tested concentrations with the percent of viable cells exceeding 80% after 48 h incubation for both of the cell lines (Figure 3) . (Figure 4a) . Moreover, the 111 In-DOTA-CNC (ald.) and 111 In-DOTA-CNC (OH) NPs were also incubated in 2 mM of EDTA (excess) at 37 ºC for 120 h period in order to evaluate the potential for transchelation of 111 In with another ligand outcompeting the DOTA chelator. The radio-TLC was acquired to monitor the transchelation. In the radio-TLC setup, the 111 In-EDTA complex moves along with the solvent front while the 111 In-DOTA-CNCs are retained at the origin. The results revealed that there was approximately 9% of 111 In transchelation into EDTA over 120 h incubation for both formulations (Figure 4b) , which is in good agreement with the reported stability of the 111 In-DOTA complex. [43] [44] Additionally, challenge with trivalent iron was conducted to simulate (Figure 4b) . This suggests that the two labeling methods used do not yield radiolabeled products of drastically different stability prompting the use of either in vivo. EDTA and Fe 3+ challenges of 111 In-DOTA-CNC NPs (n=3).
Ex vivo biodistribution
The ex vivo biodistribution evaluation of the non-targeted nanostructured carrier in animal models is a preliminary step toward the assessment of their potential for theranostic (therapeutic and diagnostic)
applications. The biodistribution of radioactivity after injection of DOTA-CNC (ald.) and DOTA-CNC (OH) NPs was studied in healthy female CD-1 mice and in 4T1-tumor bearing Balb/c female mice in order to compare the distribution profiles of both types of CNC NPs in both animal models, the latter bearing an aggressive mammary fat pad tumor with the potential of nanomaterial accumulation by the enhanced permeation and retention (EPR) effect. The DOTA-CNC (ald.) and DOTA-CNC (OH) NPs were successfully labeled with 111 In, showing 99.3% and 99.5% radiochemical purity, respectively (Figure S5a-S5b) . The final concentration of 111 In-DOTA-CNC NPs before injection was fixed at 2 mg/kg in 150 µl formulation and the injected activities were 0.1 and 0.9 MBq for 111 In-DOTA-CNC (ald.) and 111 In-DOTA-CNC (OH) NPs, respectively. The greater number of DOTA chelator groups conjugated to the CNC using the non-site-specific CDI activation explains the difference in the injected 20 activity, as more 111 In was chelated by DOTA-CNC (OH) than by 111 In-DOTA-CNC (ald.). However,
given the inherent sensitivity of radiometric detection methods, the hydrazone linkage is also a viable labeling strategy for ex vivo studies, as it renders a large portion of the surface -OH groups in the CNC available for the subsequent conjugation of therapeutic payloads and fluorescent labels. Both formulations of 111 In-DOTA-CNC NPs were intravenously injected to the mice. The animals were sacrificed and select tissues were dissected for gamma counting at 6, 24, and 48 h post injection (p.i.).
The uptake of radioactivity in an individual tissue was measured by automatic gamma counter and reported as a mean %ID/g of tissue (n=3-5) (Figure 5) . Overall, both formulations of 111 In-DOTA-CNC NPs showed hepatic (20-30 %ID/g), splenic (15-30 %ID/g), and pulmonary (10-40 %ID/g) accumulations, while only a small uptake was seen in the kidney (1-5 %ID/g) after 6, 24, and 48 h p.i.
This demonstrates the high uptake of CNC NPs in mononuclear phagocyte system (MPS), which is in agreement with the behavior and clearance of nontargeted NPs in vivo. 45 Moreover, there were no major uptake changes observed in heart, muscle, tibia and occipital bones, brain, and the 4T1 tumor over 48 h. Interestingly, there was a high accumulation of radioactivity after injection of 111 In-DOTA-CNC (OH) NPs in lung (125-150 %ID/g) at 6 h p.i in both animal models, but this drastically decreased within the first 24 h p.i. (Figure 5c and 5d ). This might be due to the observed increase of the ζ-potential of DOTA-CNC (OH) NPs comparing to the unmodified CNC NPs ( Table 1) , which might affect the dispersion stability and circulation of the DOTA-CNC NPs in vivo. Further optimization of CNC surface functionalization and conjugation of targeting ligands needs to be carried out in order to improve the biodistribution profile and reduce the MPS uptake of the CNC. Only a slight radioactivity uptake in tumor (0.30-0.75 %ID/g) was seen, although the percentage of administered NPs reaching the tumor through EPR effect can be exploited to 5% maximum regardless of the nanoparticle type 46 (Figure S6) . However, the NP surface chemistry and cancer-specific factors (e.g., tumor type, growth rate, location and interstitial pressure) have to be taken into consideration in order to elucidate the behavior of a specific type of NPs in the intrinsically heterogeneous tumor microenvironment. [47] [48] Therefore, the introduction of specific active targeting moiety and surfacestabilizing coating, such as PEGylation, to the CNC surface might enhance the tumor-targeting capability, prolong systemic circulation and reduce the uptake in MPS.
In vivo SPECT/CT imaging
The which is related to the stability of the injected dispersion, and we have aimed to obviate these problems by using a lower injected dose as well as improving the dispersion stability of the DOTA-CNC. Santos, Hélder A.; Airaksinen, Anu J.; Kostiainen, Mauri A.; Sarparanta, Mirkka liquid-liquid extraction was performed in order to remove water soluble by products and DMF with 2×20 mL ethyl acetate, 10 mL water, and 10 mL saturated brine solution. The combined organic layer was dried over sodium sulfate (Na2SO4) before filtered through Whatman TM filter paper (ϕ = 55 mm, GE Healthcare Life Sciences, Buckinghamshire, UK) and evaporated to dryness.
The product was re-dissolved in 1 mL of MeOH, and then 3 mL of ACS reagent grade 37% HCl solution was added. The Boc-deprotection reaction was left agitating in an open system under the fume hood for 4 h. All solvents were removed by vacuum rotary evaporator. The product was repeatedly washed and evaporated with 7× 6 mL of DCM in order to remove the concentrated HCl.
The viscous yellowish oil product was again re-dissolved in 1 mL of MeOH and the solution was passed through a reverse-phase Sep-Pak ® Plus C18 SPE cartridge (Waters Corporation, Milford, MA, USA), which was preconditioned with 2 mL of acetonitrile and 10 mL of water. The DOTAhydrazide was eluted out from the C18 cartridge by 1.5 mL of acetonitrile:water (70:30) mixture.
The eluted solution was evaporated to dryness and characterized by 1 H-NMR, 13 
